HELICOBACTER PYLORI - 06/09/11
Doi : 10.1016/S0025-7125(05)70279-0
Akiko Shiotani, MD, PhD c, Zhannat Z. Nurgalieva, MD a, b, Yoshio Yamaoka, MD, PhD a, David Y. Graham, MD a, b
a Department of Medicine, Veterans Affairs Medical Center (YY, ZZN, DYG)
b Departments of Medicine and Molecular Virology, Baylor College of Medicine, Houston, Texas (ZZN, DYG)
c Second Department of Internal Medicine, Wakayama Medical College, Wakayama, Japan (AS)
Résumé |
Helicobacter pylori infection is now recognized as a serious transmissible infectious disease. H. pylori is not associated with disease; it causes disease: peptic ulcers, gastric cancer, and primary B-cell gastric lymphoma. H. pylori is a curable chronic destructive bacterial infection. This article addresses the current approach to diagnosis and therapy, new considerations regarding whom to treat, and the role of putative virulence factors in disease causation.
Le texte complet de cet article est disponible en PDF.Plan
| Address reprint requests to David Y. Graham, MD, Veterans Affairs Medical Center (111D), 2002 Holcombe Boulevard, Houston, TX 77030, e-mail: dgraham@bcm.tmc.edu |
© 2000
W. B. Saunders Company. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 84 - N° 5
P. 1125-1136 - septembre 2000 Retour au numéro
Article précédent
- ADVANCES IN INFLAMMATORY BOWEL DISEASE
- Brian R. Stotland, Robert B. Stein, Gary R. Lichtenstein
- GASTROESOPHAGEAL REFLUX DISEASE AND BARRETT'S ESOPHAGUS
- David A. Katzka, Anil K. Rustgi
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?